Literature DB >> 10408188

[Progressive multifocal leukoencephalopathy].

J C Wasmuth1, A Wasmuth-Pietzuch, U Spengler, J K Rockstroh.   

Abstract

PATHOGENESIS: Progressive multifocal leukoencephalopathy is a demyelinating disease of the central nervous system caused by infection and reactivation of JC-virus. About 5% of all HIV-infected patients develop this fatal disease. Although pathogenesis is not completely understood, progressive multifocal leukoencephalopathy is thought to be a persistent infection. The kidneys, bone marrow, peripheral blood lymphocytes and the brain itself are candidates for latency sites of JC-virus. Loss of T-helper-cells in the course of HIV-infection or other immunosuppressive states result in reactivation of JC-virus. DIAGNOSIS: Progressive multifocal leukoencephalopathy can be diagnosed by focal neurological symptoms, radiographic signs in magnetic resonance imaging and detection of JC-virus in brain tissue or cerebrospinal fluid. TREATMENT: A specific therapy is not yet available or established. Highly active antiretroviral therapy (HAART) and cidofovir are promising and may prove useful in the near future.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408188     DOI: 10.1007/bf03045050

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  121 in total

1.  JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML.

Authors:  H T Agostini; C F Ryschkewitsch; R Mory; E J Singer; G L Stoner
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

2.  JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships.

Authors:  B L Padgett; C M Rogers; D L Walker
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

3.  2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy.

Authors:  B Elliot; I Aromin; R Gold; T Flanigan; M Mileno
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

4.  Genetic characterization of JC virus Tokyo-1 strain, a variant oncogenic in rodents.

Authors:  M Matsuda; M Jona; K Yasui; K Nagashima
Journal:  Virus Res       Date:  1987-04       Impact factor: 3.303

5.  Polyomavirus-infected oligodendrocytes and macrophages within astrocytes in progressive multifocal leukoencephalopathy (PML).

Authors:  R Mesquita; M Björkholm; M Ekman; G Bogdanovic; P Biberfeld
Journal:  APMIS       Date:  1996-02       Impact factor: 3.205

6.  [Anatomo-pathological features of JCV infection in patients with acquired immunodeficiency syndrome (AIDS). Histological, immunohistochemical, and ultrastructural study including the in situ hybridization technique of 54 AIDS autopsies].

Authors:  R Boldorini; S Cristina; L Vago; G R Trabattoni; G Costanzi
Journal:  Pathologica       Date:  1993 Jan-Feb

7.  Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain.

Authors:  H Reiber; P Lange
Journal:  Clin Chem       Date:  1991-07       Impact factor: 8.327

8.  The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS.

Authors:  P N Ranganathan; K Khalili
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

9.  Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid.

Authors:  T Weber; R W Turner; S Frye; W Lüke; H A Kretzschmar; W Lüer; G Hunsmann
Journal:  AIDS       Date:  1994-01       Impact factor: 4.177

10.  A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.

Authors:  F Chen; J Z Zou; L di Renzo; G Winberg; L F Hu; E Klein; G Klein; I Ernberg
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  3 in total

1.  [A rare cause of a progressive speech impairment].

Authors:  J G Heckmann; S Ernst; B Kempf; R Hebecker; T Reithmeier; C M Wendtner
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-07-28       Impact factor: 0.840

2.  Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy.

Authors:  Christoffer Kraemer; Stefan Evers; Thorsten Nolting; Gabriele Arendt; Ingo W Husstedt
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

3.  CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages.

Authors:  Corinna Trebst; Susan M Staugaitis; Pia Kivisäkk; Don Mahad; Martha K Cathcart; Barbara Tucky; Tao Wei; Mysore R Sandhya Rani; Richard Horuk; Kenneth D Aldape; Carlos A Pardo; Claudia F Lucchinetti; Hans Lassmann; Richard M Ransohoff
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.